Brightstar Partners
Brightstar Partners, established in 2002 and located in Cambridge, United Kingdom, is a venture capital and development firm focused on early-stage investments in technology start-ups, particularly in the fields of medical devices, diagnostics, and digital systems. The team at Brightstar combines extensive experience in technology spin-outs from corporate labs with a strong entrepreneurial background. Their expertise spans strategy, intellectual property commercialization, corporate finance, negotiations, and legal structuring. Brightstar Partners aims to support early opportunities by refining business propositions and enhancing commercialization strategies, thereby providing essential skills and experience to emerging ventures.
Regenerys Ltd. develops and sells regenerative medicine products focused on bioprocessing and biostorage. The company offers Myskin, a treatment for serious burns and hard-to-heal wounds that utilizes cultured autologous cells from the patient's own skin, and Cryoskin, which also employs autologous cells for burn treatment. Additionally, Regenerys provides Adiposet, a service designed to enhance cosmetic outcomes in breast cancer surgery and other procedures by allowing the storage and return of adipose tissue for lipomodellin. The firm also delivers third-party bioprocessing and biostorage services through its laboratories. Regenerys serves both NHS and private healthcare providers across the United Kingdom and Europe. Established in 2011, it is headquartered in Cambridge, United Kingdom.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.